Patients with obesity are part of a worldwide epidemic that has serious consequences for health and substantial impacts on society and healthcare expenditures. The nearly 40% of Americans with obesity require sensitive management to overcome stigma; clinicians must increase their own and their patients’ understanding that obesity is a chronic disease related to metabolic dysfunctions and not a personal failing. Clinicians thus need effective strategies for engaging patients in tackling and managing their obesity. This Expert Insights provides practical knowledge on the pathophysiology of obesity, tips on motivational interviewing to engage patients, risk assessment, an introduction to recommended lifestyle modification strategies, and guidance on choosing pharmacologic treatments. At points throughout the activity, Dr Caroline Apovian, MD, a leading obesity researcher at Boston University School of Medicine, shares her approaches to effective management of patients with obesity.
eNewsletter with interactive benchmarking and audio commentary
After completing this activity, participants should be better able to:
- Identify hormonal influences, energy regulation, and metabolic adaptations in weight control and weight loss maintenance
- Apply a chronic disease management approach to patients with obesity, including screening/diagnosis and risk assessment
- Incorporate pharmacotherapy as part of a strategy for obesity management based on guideline recommendations, efficacy and safety considerations, and patient factors
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 0.75 hours of pharmacology credit
Nurse planner: Jeffrey Kwong, DNP, MPH, ANP-BC, ACRN, Rutgers University
AAPA Credit Designation
Continuing Education Alliance has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until December 27, 2020. PAs should only claim credit commensurate with the extent of their participation.
PA planner: Mark P. Christiansen, PhD, PA-C, University of the Pacific, Sacramento, California
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Novo Nordisk, Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Apovian: consultant: EnteroMedics, Ferring, Gelesis, Merck, Novo Nordisk, Nutrisystem, Orexigen, Rhythm, Sanofi-Aventis, Scientific Intake, SetPoint Health, Takeda, Xeno Biosciences, Zafgen; research/grant support: Aspire Bariatrics, Gelesis, GI Dynamics, MetaProteomics, MYOS Corporation, Novo Nordisk, Orexigen, Pfizer, Takeda, The Robert C. and Veronica Atkins Foundation.
Dr Kwong: speaker: Gilead.
None of the members of the Planning Committee or CE Alliance staff have any relevant relationships to disclose, except Dr Kwong as noted above.
Participants wishing to earn CE/CME credit must:
- Review the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hour.
Release date: December 27, 2019
Expiration date: December 27, 2020
© 2020 Practicing Clinicians Exchange. All Rights Reserved. 97419NPCE